Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tango Therapeutics, Inc.

NASDAQ: TNGX · Life Sciences · 8 alerts · CIK 1819133

Share price
$24.17Close, Nov 16
Market cap
$4.1B
Shares outstanding
169.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tango Therapeutics, Inc. filings on SEC EDGAR ↗

6:36 AM ET 8-K
Clinical Trial Data

Tango Therapeutics Clinical Trial Data

Tango Therapeutics announced updated Phase 1/2 clinical trial results for vopimetostat in combination with daraxonrasib, showing an 82% objective response rate in patients with MTAP-deleted and RAS-mutant pancreatic cancer. The data demonstrated a 9-month progression-free survival rate of 88%, leading the company to plan a registrational Phase 3 trial in the first half of 2027.

Counterparty
Revolution Medicines, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.